WebDec 16, 2024 · The BinaxNOW COVID-19 Ag Card 2 Home Test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from … WebAlere BinaxNOW® Influenza A & B Card 2 MUST be read by the Alere™ Read … The first rapid antigen influenza test to achieve 510(k) clearance as … Alere Reader provides objective result interpretation #222455; 11; BD #245000;
Point-of-Care Analyzer Kit Binaxnow® 22 Tests CLIA Waived
WebAfinion 2 Analyzer. AlinIQ. AneuVysion. ARCHITECT Clinical Chemistry Analyzers. ARCHITECT Immunoassay Analyzers. B. BinaxNow Influenza A&B Card. C. CELL-DYN Hematology Analyzers. Cholestech LDX Analyzer. CP 3000 Coagulation System. D. Determine HIV-1/2 Ag/Ab Combo. I. ID NOW. IntelliFISH. i-STAT 1. i-STAT Alinity. i … WebThe performance characteristics of two commercially available rapid tests for influenza, the BD Veritor System for Flu A+B (BD) and the Alere BinaxNOW influenza A&B card (BN), were evaluated using 200 frozen clinical specimens collected from January 2011 to June 2012 from pediatric patients. bl2 python sdk
Alere Achieves FDA Clearance for Alere™ Reader Platform and …
WebMar 5, 2024 · The BinaxNOW Influenza A & B Card 2 test provides an advancement in lateral-flow testing technology. The card can be easily used by healthcare staff in physician offices and hospitals.... WebThe BinaxNOW COVID-19 Ag Card is a lateral flow immunoassay for the qualitative detection of the nucleocapsid protein antigen to SARS-CoV-2 directly from anterior nasal (nares) swab specimens. ... WebDevice Identifier (DI) Information. Brand Name: Alere BinaxNOW Influenza A & B Card 2. Version or Model: 575-000. Commercial Distribution Status: In Commercial Distribution. Catalog Number: Company Name: Alere Scarborough, Inc. Primary DI Number: 10811877010156. Issuing Agency: GS1. Commercial Distribution End Date: bl2 pearlescent weapons